339 related articles for article (PubMed ID: 15836467)
21. Discovery of piperazin-1-ylpyridazine-based potent and selective stearoyl-CoA desaturase-1 inhibitors for the treatment of obesity and metabolic syndrome.
Zhang Z; Sun S; Kodumuru V; Hou D; Liu S; Chakka N; Sviridov S; Chowdhury S; McLaren DG; Ratkay LG; Khakh K; Cheng X; Gschwend HW; Kamboj R; Fu J; Winther MD
J Med Chem; 2013 Jan; 56(2):568-83. PubMed ID: 23245208
[TBL] [Abstract][Full Text] [Related]
22. SCD1 deficiency protects mice against ethanol-induced liver injury.
Lounis MA; Escoula Q; Veillette C; Bergeron KF; Ntambi JM; Mounier C
Biochim Biophys Acta; 2016 Nov; 1861(11):1662-1670. PubMed ID: 27477676
[TBL] [Abstract][Full Text] [Related]
23. Novel substituted heteroaromatic compounds as inhibitors of stearoyl-CoA desaturase.
Dobrzyn P; Dobrzyn A
Expert Opin Ther Pat; 2010 Jun; 20(6):849-53. PubMed ID: 20205608
[TBL] [Abstract][Full Text] [Related]
24. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss.
Cohen P; Miyazaki M; Socci ND; Hagge-Greenberg A; Liedtke W; Soukas AA; Sharma R; Hudgins LC; Ntambi JM; Friedman JM
Science; 2002 Jul; 297(5579):240-3. PubMed ID: 12114623
[TBL] [Abstract][Full Text] [Related]
25. Development of a novel LC/MS method to quantitate cellular stearoyl-CoA desaturase activity.
Dillon R; Greig MJ; Bhat BG
Anal Chim Acta; 2008 Oct; 627(1):99-104. PubMed ID: 18790132
[TBL] [Abstract][Full Text] [Related]
26. Stearoyl-CoA Desaturase 1 (SCD1) is a key factor mediating diabetes in MyD88-deficient mice.
Yokoyama S; Hosoi T; Ozawa K
Gene; 2012 Apr; 497(2):340-3. PubMed ID: 22326531
[TBL] [Abstract][Full Text] [Related]
27. Recent insights into stearoyl-CoA desaturase-1.
Ntambi JM; Miyazaki M
Curr Opin Lipidol; 2003 Jun; 14(3):255-61. PubMed ID: 12840656
[TBL] [Abstract][Full Text] [Related]
28. Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice.
Flowers JB; Rabaglia ME; Schueler KL; Flowers MT; Lan H; Keller MP; Ntambi JM; Attie AD
Diabetes; 2007 May; 56(5):1228-39. PubMed ID: 17369521
[TBL] [Abstract][Full Text] [Related]
29. Metabolic reprogramming of the heart through stearoyl-CoA desaturase.
Dobrzyn P; Bednarski T; Dobrzyn A
Prog Lipid Res; 2015 Jan; 57():1-12. PubMed ID: 25482956
[TBL] [Abstract][Full Text] [Related]
30. Evidence that the anti-obesity effect of conjugated linoleic acid is independent of effects on stearoyl-CoA desaturase1 expression and enzyme activity.
Kang K; Miyazaki M; Ntambi JM; Pariza MW
Biochem Biophys Res Commun; 2004 Mar; 315(3):532-7. PubMed ID: 14975733
[TBL] [Abstract][Full Text] [Related]
31. Hepatic knockdown of stearoyl-CoA desaturase 1 via RNA interference in obese mice decreases lipid content and changes fatty acid composition.
Xu H; Wilcox D; Nguyen P; Voorbach M; Smith H; Brodjian S; Suhar T; Reilly RM; Jacobson PB; Collins CA; Landschulz K; Surowy TK
Front Biosci; 2007 May; 12():3781-94. PubMed ID: 17485339
[TBL] [Abstract][Full Text] [Related]
32. An integrative metabolism approach identifies stearoyl-CoA desaturase as a target for an arachidonate-enriched diet.
Mutch DM; Grigorov M; Berger A; Fay LB; Roberts MA; Watkins SM; Williamson G; German JB
FASEB J; 2005 Apr; 19(6):599-601. PubMed ID: 15670975
[TBL] [Abstract][Full Text] [Related]
33. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
34. Loss of stearoyl-CoA desaturase 1 rescues cardiac function in obese leptin-deficient mice.
Dobrzyn P; Dobrzyn A; Miyazaki M; Ntambi JM
J Lipid Res; 2010 Aug; 51(8):2202-10. PubMed ID: 20363835
[TBL] [Abstract][Full Text] [Related]
35. Stearoyl-CoA desaturase deficiency, hypercholesterolaemia, cholestasis and diabetes.
Attie AD; Flowers MT; Flowers JB; Groen AK; Kuipers F; Ntambi JM
Novartis Found Symp; 2007; 286():47-53; discussion 54-7, 162-3, 196-203. PubMed ID: 18269173
[TBL] [Abstract][Full Text] [Related]
36. Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1).
Cohen P; Friedman JM
J Nutr; 2004 Sep; 134(9):2455S-2463S. PubMed ID: 15333742
[TBL] [Abstract][Full Text] [Related]
37. Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1-/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation.
Binczek E; Jenke B; Holz B; Günter RH; Thevis M; Stoffel W
Biol Chem; 2007 Apr; 388(4):405-18. PubMed ID: 17391062
[TBL] [Abstract][Full Text] [Related]
38. Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha.
Miyazaki M; Dobrzyn A; Sampath H; Lee SH; Man WC; Chu K; Peters JM; Gonzalez FJ; Ntambi JM
J Biol Chem; 2004 Aug; 279(33):35017-24. PubMed ID: 15180999
[TBL] [Abstract][Full Text] [Related]
39. Probing the role of stearoyl-CoA desaturase-1 in hepatic insulin resistance.
Flowers MT; Miyazaki M; Liu X; Ntambi JM
J Clin Invest; 2006 Jun; 116(6):1478-81. PubMed ID: 16741573
[TBL] [Abstract][Full Text] [Related]
40. Sterculic oil, a natural inhibitor of SCD1, improves the metabolic state of obese OLETF rats.
Ortinau LC; Nickelson KJ; Stromsdorfer KL; Naik CY; Pickering RT; Haynes RA; Fritsche KL; Perfield JW
Obesity (Silver Spring); 2013 Feb; 21(2):344-52. PubMed ID: 23404766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
